Categories U.S. Markets News

Does McDonald’s French fries cure baldness? Here’s the truth

McDonald’s recently had its famous French fries in news for the weirdest of reasons. A study by Biomaterials noted that a chemical found in the fries was used by researchers at a Japanese University to grow hair on mice.

Thanks to some news articles, the report soon created rumors that the fries would cure baldness in human beings. Before you ditch your hair cream for junk food, let’s find out the truth.

As per the McD site, their French fries contain the following ingredients: potatoes, vegetable oil, natural beef flavor, dextrose, sodium acid pyrophosphate and salt. Apart from these, in small font at the end of the page, the company says that it uses “vegetable oil blend with citric acid added as a processing aid and dimethylpolysiloxane to reduce oil splatter when cooking.”

Drugs.com states that this chemical is otherwise used in cosmetic and hygiene products such as make-up, sunscreen and deodorants as a conditioning agent. Though the chemical is believed to be carcinogenic under high temperature or excess intake, FDA has not yet declared it as dangerous.

Coming back to hair growth, dimethylpolysiloxane is the same chemical that was used by the Japanese researchers to experiment on mice. The face of the matter is that even the researchers have so far not been able to infer that the chemical spurs hair growth. They have stated that more studies are required for conclusive results.     

So before you recommend French fries to your bald friend next time, remember this article. I’m lovin’ it anyways, even without any cure!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top